Image

University of Illinois Cancer Center: Summer CME Series
Session 2 - General Oncology | June 18, 2025
Evaluation Questionnaire

UICMES | Session 2 | Evaluation | June 18, 2025
We greatly value your opinion. Please complete this evaluation form at the conclusion of this activity. Your responses will be used in future planning of activities and materials.
I am a:

Upon completion of this activity I am better able to:

Discuss how to incorporate the latest advancements in the management of early-stage and late-stage lung cancer, including emerging therapeutic approaches.
Analyze new developments in pancreatic cancer treatment, with a focus on novel therapies and evolving clinical guidelines.
Assess the expanding role of antibody-drug conjugates (ADCs) in oncology and determine their appropriate integration into treatment strategies.
Evaluate current approaches to CNS metastases management, assessing progress and identifying areas for continued improvement in patient care.

Please indicate the extent of your agreement with the following statements:

The faculty for this activity were effective.
The education resources and/or handouts provided to me at the educational activity are useful to my practice.
Overall, was this fair, balanced and free from commercial bias?
Of the patients you will see in the next week, about how many will benefit from the information you learned today?
Based on what I learned today, I will improve my practice by incorporating the following (check all that apply):
Which ONE delivery method do you find the most effective for CME/CE learning?

Please rate the professional practice value of each of the following in terms of improving your practice:

Today's CME event:
Direct to consumer advertising:
Sales representative visits:
Promotional/other non-certified education:
Based on your experience, which of the following are the primary barriers to implementing changes in practice (check all that apply):
What motivated you to participate in this activity? (check all that apply)